Recalls / Class II
Class IIF-0789-2023
Product
PROSANTE TSOYFLR 5P MNCD 50LB BG/21P, PROSANTE TSOYFLR 5P MNCD 25LB BG, PROSANTE TSOYFLR 5P MNCD 50LB BG, PROSANTE TSOYFLR 5P MNCD 800LB TT; distributed paper bags and bulk totes
- Type
- Food
- Affected lot / code info
- 100001404-00923CHXTA 100001404-01023CHXTA 100001404-01123CHXTA 100001404-04523CHXTA 100001404-04623CHXTA 100001404-04723CHXTA 100001404-06523CHXTA 100001404-06623CHXTA 100001404-06723CHXTA 100001404-28322CHXTA 100001404-28422CHXTA 100001404-28522CHXTA 100001404-30422CHXTA 100001404-30522CHXTA 100001404-30622CHXTA 100001404-31822CHXTA 100001404-31922CHXTA 100001404-32022CHXTA 100001404-33222CHXTA 100001404-33322CHXTA 100001404-33422CHXTA 100001404-34622CHXTA 100001404-34722CHXTA 100001404-34822CHXTA 100001406-01623CHXEA 100001406-01723CHXEA 100001406-03923CHXEA 100001406-07523CHXEA 100001406-08623CHXEA 100001406-29222CHXEA 100001406-30522CHXEA 100001406-30622CHXEA 100001406-30722CHXEA 100001406-30822CHXEA 100001406-34022CHXEA 100001406-34122CHXEA 100001406-34222CHXEA 100001406-35422CHXEA 100001406-35522CHXEA 100001406-35622CHXEA 130012710-05223CHXEA 130012710-05323CHXEA 130012710-06523CHXEA 130012710-06623CHXEA 130012710-06723CHXEA 130012710-06823CHXEA 130012710-08723CHXEA 130012710-08823CHXEA 130015053-01823CHXEA 130015053-01923CHXEA 130015053-29222CHXEA 130015053-29422CHXEA 130015053-30422CHXEA 130015053-30822CHXEA 130015053-31322CHXEA 130015053-31422CHXEA
- Quantity
- 4,858,300
Why it was recalled
Products with a gluten free claim may contain gluten levels above 20 ppm.
Recalling firm
- Firm
- Cargill, Inc Corporate Headquarters
- Notification channel
- Type
- Voluntary: Firm initiated
- Address
- 15407 McGinty Rd W, Wayzata, Minnesota 55391-2365
Distribution
- Distribution pattern
- Nationwide United States, Canada, Chile, Costa Rica, Guatemala, Mexico, and United Kingdom
Timeline
- Recall initiated
- 2023-03-30
- FDA classified
- 2023-05-01
- Posted by FDA
- 2023-05-10
- Terminated
- 2023-06-08
- Status
- Terminated
Source: openFDA Food Enforcement endpoint. Recall record F-0789-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings.